Response to the study: ‘Syringe plunger contamination by hazardous drugs: A comparative study,’ by Stephen T Smith and Mark C Szlaczky 1

Abstract

Get full access to this article

View all access options for this article.

References

Smith ST and Szlaczky MC. Syringe plunger contamination by hazardous drugs: A comparative study. J Oncol Pharm Practice 2014; 20(5), published online March.

Wick

Slawson

Jorgenson

. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. AJHP 2003; 60: 2314–2320.

Harrison

Peters

Bing

. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. AJHP 2006; 63: 1736–1744.

Sessink

Connor

Jorgenson

. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. J Oncol Pharm Pract 2011; 17: 39–48.

Sessink

. Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device. Hosp Pharm 2013; 48: 204–212.